Search research articles
Contact Us
Filters
Showing results (51-60 of 140) with videos related to
Page
of 14
Sort By:
The American Journal of Psychiatry
|
May 1, 1992
White matter hyperintensity signals in psychiatric and nonpsychiatric subjects
F W Brown, R J Lewine, P A Hudgins, et al.
Psychopharmacology Bulletin
|
January 1, 1985
Cortisol and prolactin responses to dexamethasone in major depression, chronic pain, and chronic pain with major depression
J H Atkinson, E F Kremer, S C Risch, et al.
Psychosomatics
|
October 1, 1983
Neuroendocrine function and endogenous opioid peptide systems in chronic pain
J H Atkinson, E F Kremer, S C Risch, et al.
Psychopharmacology Bulletin
|
October 26, 2002
Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)
C L DeVane, J S Markowitz, H L Liston, et al.
Schizophrenia Research
|
May 1, 1995
Differences in qualitative brain morphology findings in schizophrenia, major depression, bipolar disorder, and normal volunteers
R R Lewine, P Hudgins, F Brown, et al.
Psychopharmacology
|
January 1, 1986
Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release
D S Janowsky, S C Risch, B Kennedy, et al.
Journal of Clinical Psychopharmacology
|
March 1, 1981
Use of dexamethasone suppression test in clinical psychiatry
N H Kalin, S C Risch, D S Janowsky, et al.
Biological Psychiatry
|
April 1, 1991
The effects of physostigmine infusion on patients with panic disorder
M H Rapaport, S C Risch, J C Gillin, et al.
Life Sciences
|
October 6, 1986
Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone
K T Britton, G Lee, R Dana, et al.
Biological Psychiatry
|
November 1, 1988
The effect of bright light on plasma prolactin
W F Byerley, S C Risch, J Jachna, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 140) with videos related to
Sort By:
Page
of 14
The American Journal of Psychiatry
|
May 1, 1992
White matter hyperintensity signals in psychiatric and nonpsychiatric subjects
F W Brown, R J Lewine, P A Hudgins, et al.
Psychopharmacology Bulletin
|
January 1, 1985
Cortisol and prolactin responses to dexamethasone in major depression, chronic pain, and chronic pain with major depression
J H Atkinson, E F Kremer, S C Risch, et al.
Psychosomatics
|
October 1, 1983
Neuroendocrine function and endogenous opioid peptide systems in chronic pain
J H Atkinson, E F Kremer, S C Risch, et al.
Psychopharmacology Bulletin
|
October 26, 2002
Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)
C L DeVane, J S Markowitz, H L Liston, et al.
Schizophrenia Research
|
May 1, 1995
Differences in qualitative brain morphology findings in schizophrenia, major depression, bipolar disorder, and normal volunteers
R R Lewine, P Hudgins, F Brown, et al.
Psychopharmacology
|
January 1, 1986
Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release
D S Janowsky, S C Risch, B Kennedy, et al.
Journal of Clinical Psychopharmacology
|
March 1, 1981
Use of dexamethasone suppression test in clinical psychiatry
N H Kalin, S C Risch, D S Janowsky, et al.
Biological Psychiatry
|
April 1, 1991
The effects of physostigmine infusion on patients with panic disorder
M H Rapaport, S C Risch, J C Gillin, et al.
Life Sciences
|
October 6, 1986
Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone
K T Britton, G Lee, R Dana, et al.
Biological Psychiatry
|
November 1, 1988
The effect of bright light on plasma prolactin
W F Byerley, S C Risch, J Jachna, et al.
Page
of 14